Trial Profile
A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary) ; Niclosamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 16 Apr 2018 Status changed from active, no longer recruiting to completed.
- 11 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.